Circulating CD4posCD28neg T cells in patients with chronic kidney disease;the relation with CMV latency and atherosclerotic disease.

Circulating CD4posCD28neg T cells in patients with chronic kidney disease;the relation with CMV latency and atherosclerotic disease. - Circulating CD4posCD28neg T cells in patients with chronic kidney disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31067

Enrollment

280

Registered

2007-10-03

Start date

2007-11-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis

Interventions

None listed

Sponsors

Academisch Medisch Centrum

Lead Sponsor

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age >18 years Chronic kidney disease

Exclusion criteria

Exclusion criteria: patients suffering from: active infection malignancy auto-immune disease

Design outcomes

Primary

Measure	Time frame
1. presence of CD4+CD28- T cells in relation to stage of CKD and CMV seropositivity 2. cytotoxische quality of CD4+CD28- T cells in relation to to stage of CKD 3. presence of CD4+CD28- T cells and presence of atherosclerotic disease	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)